0

IN THIS ISSUE

JAMA

February 6, 2002, Vol 287, No. 5
Basic View  |  Expanded View
Meetings of Medical Interest FREE
Topics:
JAMA. 2002;287(5):650-654. doi:10.1001/jama.287.5.650.
Quality-of-Life and Depressive Symptoms in Postmenopausal Women After Receiving Hormone Therapy:  Results From the Heart and Estrogen/Progestin Replacement Study (HERS) Trial FREE
Mark A. Hlatky, MD; Derek Boothroyd, PhD; Eric Vittinghoff, PhD; Penny Sharp, EdD; Mary A. Whooley, MD; for the HERS Research Group
Topics: progestins, hormone replacement therapy, estrogen, depressive disorders, glycogen storage disease type vi, postmenopause, heart, quality of life, endocrine therapy
JAMA. 2002;287(5):591-597. doi:10.1001/jama.287.5.591.
Effects of Diet and Simvastatin on Serum Lipids, Insulin, and Antioxidants in Hypercholesterolemic Men:  A Randomized Controlled Trial FREE
Antti Jula, MD, PhD; Jukka Marniemi, PhD; Risto Huupponen, MD, PhD; Arja Virtanen, MSc; Merja Rastas, MSc; Tapani Rönnemaa, MD, PhD
Topics: antioxidants, simvastatin, low-density lipoproteins, diet, insulin, lipids
JAMA. 2002;287(5):598-605. doi:10.1001/jama.287.5.598.
Varicella Disease After Introduction of Varicella Vaccine in the United States, 1995-2000 FREE
Jane F. Seward, MBBS, MPH; Barbara M. Watson, MBChB; Carol L. Peterson, MD, MPH; Laurene Mascola, MD, MPH; Jan W. Pelosi, MPH; John X. Zhang, PhD; Teresa J. Maupin, RN, MA; Gary S. Goldman, PhD; Laura J. Tabony, MPH; Kimberly G. Brodovicz, MPH; Aisha O. Jumaan, PhD, MPH; Melinda Wharton, MD, MPH
Topics: chickenpox, chickenpox vaccine, human herpesvirus 3, vaccines, surveillance, medical
JAMA. 2002;287(5):606-611. doi:10.1001/jama.287.5.606.
Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry FREE
Niteesh K. Choudhry, MD, FRCPC; Henry Thomas Stelfox, MD, FRCPC; Allan S. Detsky, MD, PhD, FRCPC
Topics: conflict of interest, drug industry, guidelines, clinical practice guideline, pharmaceutical company
JAMA. 2002;287(5):612-617. doi:10.1001/jama.287.5.612.
Clinician's Corner
Medical Management of Advanced Heart Failure FREE
Anju Nohria, MD; Eldrin Lewis, MD; Lynne Warner Stevenson, MD
Topics: heart failure
JAMA. 2002;287(5):628-640. doi:10.1001/jama.287.5.628.
Long-term Efficacy of Platelet Glycoprotein IIb/IIIa Integrin Blockade With Eptifibatide in Coronary Stent Intervention FREE
J. Conor O'Shea, MD; Christopher E. Buller, MD; Warren J. Cantor, MD; A. Bleakley Chandler, MD; Eric A. Cohen, MD; David J. Cohen, MD; Ian C. Gilchrist, MD; Neal S. Kleiman, MD; Marino Labinaz, MD; Mina Madan, MD; Gail E. Hafley, MS; Robert M. Califf, MD; Michael M. Kitt, MD; John Strony, MD; James E. Tcheng, MD; for the ESPRIT Investigators
Topics: platelet glycoproteins, eptifibatide, integrins, stents, vascular, coronary
JAMA. 2002;287(5):618-621. doi:10.1001/jama.287.5.618.
Nonspecific Medication Side Effects and the Nocebo Phenomenon
Arthur J. Barsky, MD; Ralph Saintfort, MD; Malcolm P. Rogers, MD; Jonathan F. Borus, MD
Topics: adverse effects of medication, nocebo effect
JAMA. 2002;287(5):622-627. doi:10.1001/jama.287.5.622.
Postmenopausal Hormone Therapy and Quality of Life:  No Cause for Celebration
Kathryn M. Rexrode, MD, MPH; JoAnn E. Manson, MD, DrPH
Topics: hormone replacement therapy, quality of life, endocrine therapy
JAMA. 2002;287(5):641-642. doi:10.1001/jama.287.5.641.
Decisions About Cervical Spine Radiography Following Trauma
John H. Harris, Jr, MD, DSc
Topics:
JAMA. 2002;287(5):583-584. doi:10.1001/jama.287.5.583.
Decisions About Cervical Spine Radiography Following Trauma
Richard Lynch, MB, BCh, BAO, MMedSci, FRCSI
Topics:
JAMA. 2002;287(5):583-584. doi:10.1001/jama.287.5.583.
Decisions About Cervical Spine Radiography Following Trauma—Reply
Ian G. Stiell, MD, MSc, FRCPC; George A. Wells, PhD
Topics:
JAMA. 2002;287(5):583-584. doi:10.1001/jama.287.5.583.
Cost-effectiveness of Aircraft Safety Measures
Michael F. O'Rourke, MD, DSc
Topics:
JAMA. 2002;287(5):584-585. doi:10.1001/jama.287.5.583.
Cost-effectiveness of Aircraft Safety Measures—Reply
Peter W. Groeneveld, MD; Alan M. Garber, MD, PhD
Topics:
JAMA. 2002;287(5):584-585. doi:10.1001/jama.287.5.583.
Dry Eye Syndrome in Postmenopausal Women
Chris M. Peterson, MD; Jack L. Lesher, Jr, MD; Loretta S. Davis, MD
Topics:
JAMA. 2002;287(5):585-586. doi:10.1001/jama.287.5.583.
Dry Eye Syndrome in Postmenopausal Women—Reply
Debra A. Schaumberg, ScD, MPH; M. Reza Dana, MD, MPH
Topics:
JAMA. 2002;287(5):585-586. doi:10.1001/jama.287.5.583.
What Should the Public Be Told About the Risks of Ecstasy?
Richard Glen Boire, JD
Topics:
JAMA. 2002;287(5):585. doi:10.1001/jama.287.5.583.
What Should the Public Be Told About the Risks of Ecstasy?
Alan I. Leshner, PhD
Topics:
JAMA. 2002;287(5):585. doi:10.1001/jama.287.5.583.
What Should the Public Be Told About the Risks of Ecstasy?—Reply
Brian Vastag
Topics:
JAMA. 2002;287(5):585. doi:10.1001/jama.287.5.583.
Responsibilities of Physicians and Pharmacists in Preventing Drug Interactions
Judith A. Cahill, CEBS
Topics:
JAMA. 2002;287(5):586-587. doi:10.1001/jama.287.5.583.
Responsibilities of Physicians and Pharmacists in Preventing Drug Interactions—Reply
Judith K. Jones, MD, PhD; Suellen Curkendall, PhD; Earl Goehring, Jr, BA; Jeff Jianfei Guo, PhD
Topics:
JAMA. 2002;287(5):586-587. doi:10.1001/jama.287.5.583.
Does Early Identification of Deaf Newborns Lead to Later Improvements in Language Skills?
Robert E. Pickard, MD
Topics:
JAMA. 2002;287(5):587-588. doi:10.1001/jama.287.5.583.
Does Early Identification of Deaf Newborns Lead to Later Improvements in Language Skills?—Reply
Diane C. Thompson, MS; Mark Helfand, MD, MS; Robert L. Davis, MD, MPH; Heather McPhillips, MD, MPH; Tracy A. Lieu, MD, MPH; Charles J. Homer, MD, MPH
Topics:
JAMA. 2002;287(5):587-588. doi:10.1001/jama.287.5.583.
Changes in HIV-Related Deaths as a Function of Coding
Robert N. Anderson, PhD; Harry M. Rosenberg, PhD
Topics:
JAMA. 2002;287(5):588. doi:10.1001/jama.287.5.583.
Extraimmunization in Children Through 2000
Tara W. Strine, MPH; Lawrence E. Barker, PhD; Ram B. Jain, PhD; Michael L. Washington, PhD; Susan Y. Chu, PhD; Ali H. Mokdad, PhD
Topics:
JAMA. 2002;287(5):588-589. doi:10.1001/jama.287.5.583.
Bioweapons Preparedness Chief Discusses Priorities in World of 21st-Century Biology
Topics: antibiotics, anthrax disease, bioterrorism, smallpox vaccine, vaccines, violence, biological warfare agents
JAMA. 2002;287(5):573-575. doi:10.1001/jama.287.5.573.
Risk Management of Accutane
Topics: isotretinoin, risk management
JAMA. 2002;287(5):578. doi:10.1001/jama.287.5.578.
Additional Options for Preventive Treatment for Persons Exposed to Inhalational Anthrax FREE
Topics: preventive medicine, centers for disease control and prevention (u.s.), inhalational anthrax
JAMA. 2002;287(5):579. doi:10.1001/jama.287.5.579.
Return of the Prodigal Son
Topics:
JAMA. 2002;287(5):555. doi:10.1001/jama.287.5.555.
Cutting Toenails at 82
Topics:
JAMA. 2002;287(5):556. doi:10.1001/jama.287.5.556.
SUDDEN AND TEMPORARY MENTAL ABERRATION—UNCONSCIOUS AUTOMATISM—TEMPORARY IRRESPONSIBLE STATES.Medicolegal.
Topics:
JAMA. 2002;287(5):558. doi:10.1001/jama.287.5.558.
Drugs
Topics:
JAMA. 2002;287(5):645-646. doi:10.1001/jama.287.5.645.
February 6, 2002 FREE
Topics:
JAMA. 2002;287(5):655-656. doi:10.1001/jama.287.5.655.
Heart Failure FREE
Topics: heart failure
JAMA. 2002;287(5):676. doi:10.1001/jama.287.5.676.
Meetings of Medical Interest
Topics:
JAMA. 2002;287(5):650-654. doi:10.1001/jama.287.5.650.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems